Zacks Investment Research
13 Mar 2026, 14:55 UTC · 28w ago
Verdict
Headline takes no side. We score QTTB +1.00 across three claims — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a mean short-term price target of $14.33 for Q32 Bio (QTTB), representing a potential upside of 103.6% from its current price of $7.04.
So whatA significant positive consensus gap between current price and analyst targets typically attracts bullish momentum and buying interest.
More positive than 93% of claims this week
Analysts agree that Q32 Bio (QTTB) is likely to report earnings that exceed previous estimates.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 79% of claims this week
Q32 Bio (QTTB) shares have increased 83.8% over the past four weeks.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The stock has gained 83.8% recently and analysts suggest a potential upside of 103.6% with positive earnings revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
+24.6%
Price agrees with the score
$8.77 vs $7.04 close before publication (Mar 12) · not market-adjusted
QTTB chart →
